SLA 0.00% $3.34 silk laser australia limited

helens old story, page-28

  1. 566 Posts.
    Epitanman

    Conspiracy? That's your word, not mine. I don't think there is any conspiracy.

    The world is more complicated. In the field of health there is a lot of self-delusion.

    The system of publication and blind tests is established to prevent self-delusion.

    I don't wish you ill in your investment. In fact I hope SLA does take off once the blind tests for therapeutic efficacy are carried out and in the public arena. At present I'm staying out because we have virtually nothing to go on. You live in a frighteningly simple world if you think negative appraisal is motivated solely by downramping to get in cheaper.

    Compare BTA's Relenza - search for its chemical component 'zanamivir' and you will find dozens of publications based on independent testing. In fact there is even a Japanese article showing its effectiveness in equine flu. Search for Conifer Green Needle Complex (supposed therapeutically effective for many decades more than Relenza) - nothing.
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.